D. Frye
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 9
- Cancer Genomics and Diagnostics 2
- Oncology 10
- Cancer Treatment and Pharmacology 9
- Neutropenia and Cancer Infections 2
- Cancer Diagnosis and Treatment 1
- Co-authors
- Aman U. Buzdar (11 shared papers)Gabriel N. Hortobágyi (9 shared papers)Terry L. Smith (2 shared papers)Lane D. Ziegler (2 shared papers)Frankie Ann Holmes (5 shared papers)Aman U. Buzdar (3 shared papers)G. N. Hortobágyi (3 shared papers)R S Walters (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Cancer (2 papers)JAMA (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
D. Frye
19 papers receiving 1.9k citations
D. Frye's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.2k
- Cancer Research 604
- Dermatology 121
- Pulmonary and Respiratory Medicine 300
- Hematology 98
Countries citing papers authored by D. Frye
This map shows the geographic impact of D. Frye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Frye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Frye more than expected).
Fields of papers citing papers by D. Frye
This network shows the impact of papers produced by D. Frye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Frye. The network helps show where D. Frye may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Frye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer Hit paper breakdown → | 1991 | 661 |
| 2 | Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. Hit paper breakdown → | 1996 | 621 |
| 3 | 1989 | 161 | |
| 4 | 1997 | 135 | |
| 5 | 1996 | 106 | |
| 6 | 1987 | 105 | |
| 7 | 2007 | 65 | |
| 8 | The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer. | 1993 | 46 |
| 9 | Capecitabine: nursing implications of a new oral chemotherapeutic agent. | 1999 | 40 |
| 10 | 2023 | 38 | |
| 11 | 1998 | 32 | |
| 12 | 1999 | 16 | |
| 13 | 1994 | 10 | |
| 14 | Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer. | 1997 | 10 |
| 15 | Phase II study of iproplatin in metastatic breast carcinoma. | 1987 | 9 |
| 16 | 1996 | 7 | |
| 17 | 1991 | 5 | |
| 18 | 1990 | 4 | |
| 19 | 1994 | 1 |
About D. Frye
D. Frye is a scholar working on Cancer Research, Oncology, Dermatology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine, having authored 19 papers that have together received 2.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (9 papers), Chemotherapy-related skin toxicity (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Genomics and Diagnostics (2 papers), Neutropenia and Cancer Infections (2 papers), Retinal Diseases and Treatments (1 paper) and Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (604 citations), Dermatology (121 citations), Pulmonary and Respiratory Medicine (300 citations) and Hematology (98 citations). D. Frye has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Aman U. Buzdar, Gabriel N. Hortobágyi, Terry L. Smith, Lane D. Ziegler, Frankie Ann Holmes, Aman U. Buzdar, G. N. Hortobágyi, R S Walters, Rachel Leigh Theriault and Martin N. Raber. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, JAMA and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.